IOTA Pharmaceuticals


IOTA Pharmaceuticals
Fragment - based Drug Discovery
GBM Drug Bank
Glioma & Glioblastoma
WINDOW on Glioblastoma
IOTA Pharmaceuticals
April 14, 2016

PDE4NPD Consortium in collaboration with IOTA Pharmaceuticals announces PDE Toolbox for parasite drug discovery and PDE biology
As a member of the PDE4NPD consortium, IOTA Pharmaceuticals has been involved in creating the “PDE Toolbox”, detailing known and novel PDE inhibitors that can be profiled for their potential action against parasites. As well as a full range of reference PDE inhibitors, the toolbox also includes DNA constructs for PDE expression in a variety of cell types, as well as previously developed protocols and procedures for PDE biochemical analysis. The toolbox represents a “discovery matrix” to integrate the work of the PDE4NPD Consortium beyond its own work, further accelerating research in this area.